Latest developments and in vivo use of the Tet system: Ex vivo and in vivo delivery of tetracycline-regulated genes

Current Opinion in Biotechnology

Volumn 13, Issue 5, 2002, Pages 448-452

  Corbel, Stéphane Y ^a   Rossi, Fabio M V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LENTIVIRUS VECTOR; PRISTINAMYCIN; RECOMBINANT DNA; RETROVIRUS VECTOR; STREPTOGRAMIN; TETRACYCLINE; TRANSCRIPTION FACTOR;

CELL IMMORTALIZATION; DRUG DNA BINDING; GENE DELIVERY SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TARGET CELL; TARGET ORGAN; TRANSGENIC ANIMAL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALIA; LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0036810923     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00361-0     Document Type: Review

References (38)

1. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 89:1992;5547-5551.
2. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
3. Blau H.M., Rossi F.M. Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc Natl Acad Sci USA. 96:1999;797-799.
4. Baron U., Gossen M., Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 25:1997;2723-2729.
5. Urlinger S., Baron U., Thellmann M., Hasan M.T., Bujard H., Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA. 97:2000;7963-7968. Novel rtTAs were generated by mutagenesis of the original tTA. One of them (rtTA-M2) shows a 10-fold higher affinity for dox than the previous version. Thus, a lower concentration of dox is required to induce rtTA-M2 DNA binding, facilitating its use in vivo.
6. Lamartina S., Roscilli G., Rinaudo C.D., Sporeno E., Silvi L., Hillen W., Bujard H., Cortese R., Ciliberto G., Toniatti C. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther. 13:2002;199-210. This report describes a method to achieve long-term, inducible expression of a target gene in vivo by direct delivery of the tet system to skeletal muscle. The authors used the novel rtTA-M2 transcriptional activator combined with DNA electroinjection-mediated delivery to obtain regulatable expression of therapeutic levels of EPO in mouse.
7. Fussenegger M., Morris R.P., Fux C., Rimann M., von Stockar B., Thompson C.J., Bailey J.E. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol. 18:2000;1203-1208. This report describes a novel inducible system conceptually based on the tet system, but using a different antibiotic/transcription factor pair. This new system can be combined with the tet system to independently regulate multiple genes.
8. Fux C., Moser S., Schlatter S., Rimann M., Bailey J.E., Fussenegger M. Streptogramin- and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res. 29:2001;E19.
9. Robertson A., Perea J., Tolmachova T., Thomas P.K., Huxley C. Effects of mouse strain, position of integration and tetracycline analogue on the tetracycline conditional system in transgenic mice. Gene. 282:2002;65-74. This report contains an interesting analysis of the parameters influencing the efficiency of the tet system in transgenic animals.
10. Tremblay P., Meiner Z., Galou M., Heinrich C., Petromilli C., Lisse T., Cayetano J., Torchia M., Mobley W., Bujard H., et al. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci USA. 95:1998;12580-12585.
11. Deuschle U., Meyer W.K., Thiesen H.J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 15:1995;1907-1914.
12. Rossi F.M., Guicherit O.M., Spicher A., Kringstein A.M., Fatyol K., Blakely B.T., Blau H.M. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet. 20:1998;389-393.
13. Freundlieb S., Schirra-Muller C., Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med. 1:1999;4-12.
14. Zheng T., Zhu Z., Wang Z., Homer R.J., Ma B., Riese R.J. Jr, Chapman H.A. Jr, Shapiro S.D., Elias J.A. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest. 106:2000;1081-1093.
15. Zhu Z., Ma B., Homer R.J., Zheng T., Elias J.A. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem. 276:2001;25222-25229. The authors used tTS (a transcriptional silencer consisting of tetR fused to the KRAB domain from the Kid-1 protein) to suppress leaky expression of an inducible transgene in the absence of inducer. Lung-specific expression of tTS repressed an inducible IL-13 transgene by at least three orders of magnitude, and did not interfere with the ability to induce it.
16. Bohl D., Naffakh N., Heard J.M. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med. 3:1997;299-305.
17. Vigna E., Cavalieri S., Ailles L., Geuna M., Loew R., Bujard H., Naldini L. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol Ther. 5:2002;252-261. This report provides the first example of inducible gene delivery to human haematopoietic progenitors ex vivo. The authors delivered the tet system components and an inducible target gene (luciferase) with lentiviral vectors. Different primary cell types such as fibroblasts, lymphocytes, monocytes and haematopoietic progenitors were successfully infected and expressed inducible luciferase. Expression was maintained in vivo for over 20 weeks after transplantation of the engineered cells.
18. Blomer U., Naldini L., Kafri T., Trono D., Verma I.M., Gage F.H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vectorm. J Virol. 71:1997;6641-6649.
19. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
20. Kafri T., Blomer U., Peterson D.A., Gage F.H., Verma I.M. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet. 17:1997;314-317.
21. Verhoef K., Marzio G., Hillen W., Bujard H., Berkhout B. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol. 75:2001;979-987. This report describes a strategy to regulate HIV transcription and replication using the tet system. The authors replaced the TAR sequence with multimerized tetO sites and its cognate transactivator, Tat, with rtTA.
22. Sakai N., Thome J., Newton S.S., Chen J., Kelz M.B., Steffen C., Nestler E.J., Duman R.S. Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol. 61:2002;1453-1464.
23. Lindeberg J., Mattsson R., Ebendal T. Timing the doxycycline yields different patterns of genomic recombination in brain neurons with a new inducible Cre transgene. J Neurosci Res. 68:2002;248-253.
24. Smith-Arica J.R., Morelli A.E., Larregina A.T., Smith J., Lowenstein P.R., Castro M.G. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol Ther. 2:2000;579-587.
25. + T cells: half-life and survival signals in the absence of major histocompatibility complex class II molecules. J Exp Med. 191:2000;355-364.
26. Gunther E.J., Belka G.K., Wertheim G.B., Wang J., Hartman J.L., Boxer R.B., Chodosh L.A. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 16:2002;283-292.
27. Lottmann H., Vanselow J., Hessabi B., Walther R. The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic β-cells. J Mol Med. 79:2001;321-328.
28. Ye L., Chan S., Chow Y.H., Tsui L.C., Hu J. Regulated expression of the human CFTR gene in epithelial cells. Mol Ther. 3:2001;723-733.
29. Xie W., Chow L.T., Paterson A.J., Chin E., Kudlow J.E. Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice. Oncogene. 18:1999;3593-3607.
30. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lubbert H., Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA. 93:1996;10933-10938.
31. Dugray A., Geay J.F., Foudi A., Bonnet M.L., Vainchenker W., Wendling F., Louache F., Turhan A.G. Rapid generation of a tetracycline-inducible BCR-ABL-defective retrovirus using a single autoregulatory retroviral cassette. Leukemia. 15:2001;1658-1662.
32. Ralph G.S., Bienemann A., Harding T.C., Hopton M., Henley J., Uney J.B. Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors. Neuroreport. 11:2000;2051-2055.
33. Farson D., Witt R., McGuinness R., Dull T., Kelly M., Song J., Radeke R., Bukovsky A., Consiglio A., Naldini L. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther. 12:2001;981-997.
34. Sander A., Guth A., Brenner H.R., Witzemann V. Gene transfer into individual muscle fibers and conditional gene expression in living animals. Cell Tissue Res. 301:2000;397-403.
35. McGee Sanftner L.H., Rendahl K.G., Quiroz D., Coyne M., Ladner M., Manning W.C., Flannery J.G. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther. 3:2001;688-696.
36. Mizuguchi H., Hayakawa T. Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim Biophys Acta. 1568:2001;21-29.
37. Rendahl K.G., Quiroz D., Ladner M., Coyne M., Seltzer J., Manning W.C., Escobedo J.A. Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors. Hum Gene Ther. 13:2002;335-342.
38. Weber W., Fux C., Daoud El Baba M., Keller B., Weber C.C., Kramer B.P., Heinzen C., Aubel D., Bailey J.E., Fussenegger M. Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol. 20:2002;901-907.